Clinical Trial Update: Study Comparing Product 0405 to a Vehicle Control in the Treatment of Mild to Moderate Atopic Dermatitis in Pediatric Subjects [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating Product 0405 versus vehicle control for mild-to-moderate atopic dermatitis in pediatric patients has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Product 0405

Snippet

Sponsor: Fougera Pharmaceuticals Inc. | Conditions: Atopic Dermatitis | Phase 3 | Status: WITHDRAWN